US stock futures are sliding premarket as investors digest hawkish signals from the Federal Reserve and ongoing signs of strain in the manufacturing sector. With Fed officials making it clear that a December rate cut is not guaranteed, and manufacturing data painting a mixed, uncertain picture, market sentiment is becoming more cautious as investors weigh the impact of elevated yields and weaker production on broader economic growth.

Stay a step ahead of market uncertainty with undervalued stocks based on cash flows before the next move happens.

IDEXX Laboratories (IDXX) soared 14.84% after strong Q3 earnings and increased 2025 revenue guidance.

Kenvue (KVUE) jumped 12.32% following a $40B buyout offer from Kimberly-Clark (KMB).

Incyte (INCY) surged 8.65% after positive data updates for its oncology programs in advance of ASH 2025.

Is Incyte still a smart investment or just hype? Read our most popular narrative and get all the answers you need.

DuPont de Nemours (DD) sank 57.51% after spinning off Qnity Electronics and following major board and executive changes.

Kimberly-Clark (KMB) dropped 14.57% on concerns over its $40B Kenvue acquisition and potential dilution.

AST SpaceMobile (ASTS) declined 11.35%.

Look past the noise - uncover the top narrative that explains what truly matters for Kimberly-Clark's long-term success.

Earnings season heats up as major tech, financial, and consumer companies report, helping set the tone for markets this week.

Pfizer (PFE) reports Q3 results on Tuesday. This is a crucial update on pharmaceutical demand and post-pandemic profit trends.

Advanced Micro Devices (AMD) Q3 earnings on Tuesday after the bell will spotlight AI chip sales momentum and margin outlook.

Airbnb (ABNB) unveils Q3 results after market close Thursday, offering a clear read on travel demand and booking trends.

Federal Reserve Policy Signals remain in focus as officials reiterate a cautious stance. Markets are parsing for clues on the December rate path.

Kenvue (KVUE) earnings on Thursday before the market opens put the spotlight on consumer health demand following its $40 billion acquisition buzz.

Use our Portfolio or Watchlist features to track market-moving events like these and get alerts for the companies you own, free!

Don’t just follow the headlines. Act before the crowd does by tapping into our exclusive list of 3%;elm:context_link;itc:0;sec:content-canvas\\" class=\\"link \\">dividend stocks with yields > 3% delivering consistent income and strong performance in today’s market.

Ready to take control? Use our stock screener to uncover hidden gems that fit your unique investing style and receive timely alerts whenever fresh opportunities appear.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com